BeneCheck Supreme Blood Glucose Monitoring System - Taiwan Registration 390456fa874aa84c3d443501649bf6ad
Access comprehensive regulatory information for BeneCheck Supreme Blood Glucose Monitoring System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 390456fa874aa84c3d443501649bf6ad and manufactured by Qinli Biotechnology Co., Ltd. new tree factory. The authorized representative in Taiwan is GENERAL LIFE BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
390456fa874aa84c3d443501649bf6ad
Ministry of Health Medical Device Manufacturing No. 006483
Product Details
This product can quantitatively detect the blood glucose concentration of fingertips, palms or forearm microvascular whole blood and venous blood. This system is suitable for home self-testing and professional detection of the patient's microvascular whole blood glucose concentration, and also suitable for professionals to detect the patient's venous blood glucose concentration.
A Clinical chemistry and clinical toxicology
A1345 Glucose Test System
Produced in Taiwan, China
Dates and Status
Dec 02, 2019
Dec 02, 2024